Episode 51: Navigating Multiple Ventures in Biotech with Key Opinion Leader Elaine Hamm, PhD (RE-RELEASE)
Episode 51: Navigating Multiple Ventures in Biotech with Key Opinion Leader Elaine Hamm, PhD (RE-RELEASE)
Looking for insights on how to effectively manage several biotech endeavors simultaneously?
In this episode, Elaine Hamm, PhD, takes us through a day in her life in which she wears many hats—from her role as Executive in Residence at Tulane School of Medicine to leading startups like Ascend BioVentures, Cadenza Bio, CLAIRIgene, and Otologic Pharmaceutics. She even finds time to run a wine bar called The Study. Host James Zanewicz, JD, LLM, RTTP, dives into Elaine’s strategies for juggling these diverse roles and the secrets to her success.
In this episode, you’ll discover:
- The diverse biotech ventures Elaine Hamm is leading and how you can get involved.
- Practical tips for managing multiple high-stakes projects without burning out.
- Elaine’s insights into the evolving biotech landscape and how she stays ahead of the curve.
Tune in to learn how Elaine manages her wide-ranging responsibilities and what you can learn from her approach to leadership and innovation.
Links:
Connect with Elaine Hamm, PhD.
Learn more about Ascend BioVentures, Cadenza Bio, CLAIRIgene, Otologic Pharmaceutics, and The Study.
Check out Episode 4: “Executive in Residence” in Academia and Episode 5: Executive in Residence 6-Month Update.
Check out Episode 26: The Alliance for Artificial Intelligence in Healthcare.
Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.
Check out Episode 21: The Milken Institute.
Check out Episode 23: The Equalize Program.
Check out BIO on the BAYOU and make plans to attend on October 29 & 30, 2024.
Learn more about BIO from the BAYOU – the podcast, the upcoming event, and more!
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
